Quest Diagnostics Inc.
DGX Real Time Price USDRecent trades of DGX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by DGX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$410,000 Apr 21, 2025 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
-
$390,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid
-
$430,000 Oct 21, 2024 Issue: Medicare/Medicaid Health Issues
-
$410,000 Oct 21, 2024 Issue: Medicare/Medicaid Health Issues
-
$520,000 Jul 22, 2024 Issue: Medicare/Medicaid Health Issues
-
$530,000 Jan 22, 2024 Issue: Medicare/Medicaid Health Issues
-
$530,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
-
$520,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
-
$320,000 Jan 20, 2023 Issue: Medicare/Medicaid Health Issues
-
$320,000 Oct 20, 2022 Issue: Medicare/Medicaid Health Issues
-
$250,000 Jul 20, 2022 Issue: Medicare/Medicaid Health Issues
-
$190,000 Apr 19, 2022 Issue: Medicare/Medicaid Health Issues
-
$950,000 Jan 20, 2022 Issue: Health Issues Medicare/Medicaid
-
$320,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues
-
$340,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$230,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$220,000 Jan 20, 2021 Issue: Medicare/Medicaid Health Issues Homeland Security
-
$220,000 Oct 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$230,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$210,000 Apr 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$170,000 Jan 20, 2020 Issue: None
-
$210,000 Oct 21, 2019 Issue: None
-
$240,000 Jul 19, 2019 Issue: Health Issues Medicare/Medicaid
-
$270,000 Apr 22, 2019 Issue: Medicare/Medicaid Health Issues
-
$520,000 Jan 21, 2019 Issue: Health Issues Medicare/Medicaid
-
$780,000 Oct 20, 2018 Issue: Health Issues Medicare/Medicaid
-
$280,000 Jul 20, 2018 Issue: Health Issues Medicare/Medicaid
-
$270,000 Apr 20, 2018 Issue: None
-
$280,000 Jan 19, 2018 Issue: None
-
$300,000 Oct 20, 2017 Issue: None
-
$280,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
-
$240,000 Apr 20, 2017 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs
-
$260,000 Jan 20, 2017 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs
-
$270,000 Oct 20, 2016 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs
-
$290,000 Jul 19, 2016 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
-
$190,000 Apr 20, 2016 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$220,000 Jan 20, 2016 Issue: Medicare/Medicaid Defense Health Issues Medical/Disease Research/Clinical Labs
-
$200,000 Oct 20, 2015 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Defense
-
$200,000 Jul 20, 2015 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Defense Health Issues
-
$150,000 Apr 20, 2015 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues Defense
-
$130,000 Jan 19, 2015 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Defense Health Issues
-
$150,000 Oct 20, 2014 Issue: Medicare/Medicaid Defense Medical/Disease Research/Clinical Labs Health Issues
-
$160,000 Jul 21, 2014 Issue: Medicare/Medicaid Defense Health Issues
-
$160,000 Apr 18, 2014 Issue: Medicare/Medicaid Health Issues
-
$130,000 Jan 21, 2014 Issue: Medicare/Medicaid Health Issues
-
$150,000 Oct 21, 2013 Issue: Medicare/Medicaid Health Issues
-
$200,000 Jul 19, 2013 Issue: Medicare/Medicaid Health Issues
-
$190,000 Apr 19, 2013 Issue: Medicare/Medicaid Health Issues
-
$120,000 Jan 21, 2013 Issue: Medicare/Medicaid Health Issues
-
$180,000 Oct 19, 2012 Issue: Medicare/Medicaid Health Issues
-
$170,000 Jul 19, 2012 Issue: Medicare/Medicaid Health Issues
-
$190,000 Apr 18, 2012 Issue: Medicare/Medicaid Health Issues
-
$190,000 Jan 19, 2012 Issue: Medicare/Medicaid Health Issues
-
$210,000 Oct 19, 2011 Issue: Medicare/Medicaid Health Issues
-
$270,000 Oct 19, 2011 Issue: Medicare/Medicaid Health Issues
-
$200,000 Jul 18, 2011 Issue: Health Issues
-
$220,000 Jan 18, 2011 Issue: Health Issues
-
$240,000 Oct 20, 2010 Issue: Health Issues
-
$220,000 Jul 18, 2010 Issue: Health Issues
-
$190,000 Apr 17, 2010 Issue: Health Issues
-
$190,000 Jan 19, 2010 Issue: Health Issues
-
$190,000 Oct 16, 2009 Issue: Health Issues
-
$160,000 Jul 16, 2009 Issue: None
-
$160,000 Apr 20, 2009 Issue: None
-
$120,000 Jan 15, 2009 Issue: None
-
$130,000 Oct 14, 2008 Issue: None
-
$160,000 Jul 17, 2008 Issue: Medicare/Medicaid Health Issues
-
$210,000 Jul 17, 2008 Issue: Health Issues Medicare/Medicaid
-
$75,000 Feb 14, 2008 Issue: Health Issues
-
$75,000 Aug 14, 2007 Issue: Health Issues
-
$75,000 Jan 30, 2007 Issue: Health Issues
-
$60,000 Aug 10, 2006 Issue: Health Issues
-
$75,000 Jun 21, 2006 Issue: Health Issues Medicare/Medicaid
-
$45,000 Aug 24, 2005 Issue: Medicare/Medicaid
-
$50,018 Feb 23, 2005 Issue: Medicare/Medicaid
-
$75,000 Aug 24, 2004 Issue: Health Issues Medicare/Medicaid
-
$60,000 Feb 17, 2004 Issue: Medicare/Medicaid
-
$60,000 Aug 13, 2003 Issue: Medicare/Medicaid
-
$60,000 Feb 20, 2003 Issue: Medicare/Medicaid
-
$60,000 Aug 29, 2002 Issue: Medicare/Medicaid
-
$50,000 Mar 15, 2002 Issue: Medicare/Medicaid
-
$60,000 Jul 03, 2001 Issue: Medicare/Medicaid
-
$40,000 Feb 14, 2001 Issue: Medicare/Medicaid
-
$40,000 Aug 09, 2000 Issue: Medicare/Medicaid
-
$40,000 Feb 14, 2000 Issue: Medicare/Medicaid Health Issues
-
$40,000 Aug 16, 1999 Issue: Health Issues Medicare/Medicaid
Estimated quarterly lobbying spending
DGX Revenue by Segment or Geography
New patents grants
-
Patent Title: Method for determining penetration opportunity of a drug into a physician market Jan. 21, 2014
-
Patent Title: Fluorescence energy transfer by competitive hybridization Sep. 28, 2010
Federal grants, loans, and purchases
- $2,100,000 2025-06-26 00:00:00 Agency: Department of Veterans Affairs
- $687,012 2025-06-23 00:00:00 Agency: Department of Veterans Affairs
- $655,179 2025-06-23 00:00:00 Agency: Department of Veterans Affairs
- $0 2025-06-20 00:00:00 Agency: Department of Veterans Affairs
- $120,000 2025-06-18 00:00:00 Agency: Department of Health and Human Services
- $136,541 2025-06-17 00:00:00 Agency: Department of Veterans Affairs
- $28,595 2025-06-16 00:00:00 Agency: Department of Justice
- $12,497 2025-06-12 00:00:00 Agency: Department of Health and Human Services
- $985,056 2025-06-12 00:00:00 Agency: Department of Veterans Affairs
- $6,000 2025-06-12 00:00:00 Agency: Department of Justice
- $10,150 2025-06-11 00:00:00 Agency: Department of Justice
- $15,888 2025-06-09 00:00:00 Agency: Department of Justice
- $249,000 2025-06-06 00:00:00 Agency: Department of Veterans Affairs
- $170,000 2025-06-06 00:00:00 Agency: Department of Veterans Affairs
- $210,000 2025-06-06 00:00:00 Agency: Department of Veterans Affairs
- $14,000 2025-06-06 00:00:00 Agency: Department of Justice
- $54,000 2025-06-06 00:00:00 Agency: Department of Veterans Affairs
- $60,000 2025-06-06 00:00:00 Agency: Department of Veterans Affairs
- $200,000 2025-06-06 00:00:00 Agency: Department of Veterans Affairs
- $474,993 2025-06-05 00:00:00 Agency: Department of Health and Human Services
- $2,500 2025-06-04 00:00:00 Agency: Department of Justice
- $4,077 2025-06-04 00:00:00 Agency: Department of Justice
- $13,000 2025-06-03 00:00:00 Agency: Department of Justice
- $13,880 2025-06-03 00:00:00 Agency: Department of Justice
- $15,000 2025-06-03 00:00:00 Agency: Department of Justice
- $14,023 2025-06-02 00:00:00 Agency: Department of Justice
- $2,314 2025-06-02 00:00:00 Agency: Department of Justice
- $3,375,189 2025-05-29 00:00:00 Agency: Department of Veterans Affairs
- $21,000 2025-05-29 00:00:00 Agency: Department of Justice
- $14,000 2025-05-28 00:00:00 Agency: Department of Justice
- $7,000 2025-05-23 00:00:00 Agency: Department of Justice
- $16,250 2025-05-12 00:00:00 Agency: Department of Justice
- $13,000 2025-05-12 00:00:00 Agency: Department of Justice
- $4,000 2025-05-09 00:00:00 Agency: Department of Justice
- $4,989 2025-05-09 00:00:00 Agency: Department of Justice
- $16,835 2025-05-09 00:00:00 Agency: Department of Justice
- $15,888 2025-05-05 00:00:00 Agency: Department of Justice
- $10,000 2025-05-01 00:00:00 Agency: Department of Justice
- $5,000 2025-05-01 00:00:00 Agency: Department of Justice
- $55,393 2025-04-29 00:00:00 Agency: Department of Justice
- $18,240 2025-04-29 00:00:00 Agency: Department of Justice
- $4,000 2025-04-29 00:00:00 Agency: Department of Justice
- $14,000 2025-04-28 00:00:00 Agency: Department of Justice
- $14,000 2025-04-28 00:00:00 Agency: Department of Justice
- $14,000 2025-04-28 00:00:00 Agency: Department of Justice
- $1,380 2025-04-28 00:00:00 Agency: Department of Justice
- $16,835 2025-04-24 00:00:00 Agency: Department of Justice
- $574,276 2025-04-21 00:00:00 Agency: Department of Veterans Affairs
- $3,000 2025-04-21 00:00:00 Agency: Department of Justice
- $43,013 2025-04-16 00:00:00 Agency: Department of Justice
Estimated quarterly amount awarded from public contracts
Recent insights relating to DGX
Recent picks made for DGX stock on CNBC
ETFs with the largest estimated holdings in DGX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $DGX stock a Buy, Sell, or Hold?
- What is the price target for $DGX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $DGX stock?
- Who owns the most shares of $DGX stock?
- What funds own $DGX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view DGX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.